2d
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
4d
Pharmaceutical Technology on MSNPharma industry dodges tariff blow but still braces for disruptionAccording to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German pharmaceutical ...
Two European-headquartered drugmakers told Reuters this week they are sending as much of their medicines across the Atlantic ...
Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...
Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...
Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...
The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results